BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27924477)

  • 1. Assessing Anti-miR Pharmacology with miRNA Polysome Shift Assay.
    Androsavich JR
    Methods Mol Biol; 2017; 1517():103-113. PubMed ID: 27924477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysome shift assay for direct measurement of miRNA inhibition by anti-miRNA drugs.
    Androsavich JR; Sobczynski DJ; Liu X; Pandya S; Kaimal V; Owen T; Liu K; MacKenna DA; Chau BN
    Nucleic Acids Res; 2016 Jan; 44(2):e13. PubMed ID: 26384419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive Argonaute-Based RNA Immunoprecipitation for Investigation of Transcriptomic Response to Anti-miR.
    Androsavich JR
    Methods Mol Biol; 2017; 1517():91-102. PubMed ID: 27924476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of Cardiac Anti-miR-208a Therapy Is Stress Dependent.
    Eding JE; Demkes CJ; Lynch JM; Seto AG; Montgomery RL; Semus HM; Jackson AL; Isabelle M; Chimenti S; van Rooij E
    Mol Ther; 2017 Mar; 25(3):694-704. PubMed ID: 28202391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of inhibition of miRNA expression induced by anti-miRNA oligonucleotides.
    Chae DK; Ban E; Yoo YS; Baik JH; Song EJ
    Anal Bioanal Chem; 2016 Jul; 408(18):4829-33. PubMed ID: 27178549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small RNA zippers lock miRNA molecules and block miRNA function in mammalian cells.
    Meng L; Liu C; Lü J; Zhao Q; Deng S; Wang G; Qiao J; Zhang C; Zhen L; Lu Y; Li W; Zhang Y; Pestell RG; Fan H; Chen YH; Liu Z; Yu Z
    Nat Commun; 2017 Jan; 8():13964. PubMed ID: 28045030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonists of the miRNA-Argonaute 2 Protein Complex: Anti-miR-AGOs.
    Schmidt MF; Korb O; Abell C
    Methods Mol Biol; 2017; 1517():239-249. PubMed ID: 27924487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).
    Gambari R; Brognara E; Spandidos DA; Fabbri E
    Int J Oncol; 2016 Jul; 49(1):5-32. PubMed ID: 27175518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.
    Su YL; Swiderski P; Marcucci G; Kortylewski M
    Methods Mol Biol; 2019; 1974():141-150. PubMed ID: 31099000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of microRNAs in vivo with 'antagomirs'.
    Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
    Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of miR-21 by 3'/5'-Serinyl-Capped 2'-O-Methyl RNA Interspersed with 2'-O-(2-Amino-3-Methoxypropyl) Uridine Units.
    Nahar S; Kotikam V; Kumar VA; Maiti S
    Nucleic Acid Ther; 2016 Oct; 26(5):327-334. PubMed ID: 27454558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-nucleotide Modification of Anti-miRNA Oligonucleotides.
    Lennox KA; Vakulskas CA; Behlke MA
    Methods Mol Biol; 2017; 1517():51-69. PubMed ID: 27924473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate Receptor Alpha Upregulates Oct4, Sox2 and Klf4 and Downregulates miR-138 and miR-let-7 in Cranial Neural Crest Cells.
    Mohanty V; Shah A; Allender E; Siddiqui MR; Monick S; Ichi S; Mania-Farnell B; G McLone D; Tomita T; Mayanil CS
    Stem Cells; 2016 Nov; 34(11):2721-2732. PubMed ID: 27300003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of MicroRNA Delivery In Vivo.
    Brown RAM; Richardson KL; Kalinowski FC; Epis MR; Horsham JL; Kabir TD; De Pinho MH; Beveridge DJ; Stuart LM; Wintle LC; Leedman PJ
    Methods Mol Biol; 2018; 1699():155-178. PubMed ID: 29086376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function.
    Scherr M; Venturini L; Battmer K; Schaller-Schoenitz M; Schaefer D; Dallmann I; Ganser A; Eder M
    Nucleic Acids Res; 2007; 35(22):e149. PubMed ID: 18025036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Anti-miR Association with miRNA/Argonaute Complexes In Vivo.
    Zisoulis DG
    Methods Mol Biol; 2017; 1517():79-89. PubMed ID: 27924475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA biogenesis: dicing assay.
    Melo CA; Melo SA
    Methods Mol Biol; 2014; 1182():219-26. PubMed ID: 25055915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of oncogenic miRNA function by light-activated miRNA antagomirs.
    Connelly CM; Deiters A
    Methods Mol Biol; 2014; 1165():99-114. PubMed ID: 24839022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.